Stock TEVA PHARMACEUTICAL INDUSTRIES LTD (ADR)
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Teva Pharmaceutical Industries Ltd (ADR) Nasdaq

Equities

US8816242098

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Teva’s 2023 Healthy Future Report Showcases Renewed Sustainability Strategy and Ambitious Targets
BU
Alvotech - U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-FreeInterchangeable Biosimilar to Humira
AQ
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications
MT
Top Midday Stories: Shares of Eli Lilly, HSBC Get Post-Earnings Bump; BBVA Exploring Merger With Sabadell; FTC Disputes 300 'Junk' Patent Listings
MT
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications
MT
Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals
MT
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications
MT
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications
MT
Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent
MT
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
BU
Vanda Pharmaceuticals Appeal for Patents on Sleep Drug Declined by US Supreme Court
MT
Alvotech Shares Rise After Signing Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in US
MT
Alvotech Signs Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in US
MT
Teva's New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for AUSTEDO Tablets
AQ
Alvotech and Teva Announces U.S. FDA Approval of SELARSDI (ustekinumab-aekn), biosimilar to Stelara (ustekinumab)
CI
Alvotech, Teva Win US FDA Approval for Selarsdi Injection to Treat Severe Plaque Psoriasis, Psoriatic Arthritis
MT
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
BU
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
AQ
Teva Pharmaceutical Industries : Immediate Report
PU
Teva Pharmaceutical Industries : Immediate Report
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TEVA Stock
  4. Stock
  5. News Teva Pharmaceutical Industries Ltd (ADR)